Class will soon be in session at the Allergan Aesthetics headquarters. The AbbVie brand plans to open doors at its ...

Brin's been researching Botox since 1984 and is currently the chief scientific officer of Botox at the drug company Allergan. It's one of many Botox-related license plates he owns, including some ...

Allergan will acquire California-based Bonti for an upfront payment of $195 million and additional potential commercial milestone payments, subject to certain adjustments and other customary ...

Breast implants are not considered lifetime devices. The longer people have them, the greater the chances are that they will develop complications, some of which will require more surgery. Breast ...

Allergan is still on the acquisition trail following its failed merger with Pfizer, spending $85 million to acquire privately-held Topokine Therapeutics and its late-stage product for under-eye bags.

It was then that Actavis, a drug company that specializes in generic drugs and over-the-counter products, scooped up Allergan for a neat $66 billion. Here's a photo of Actavis CEO Brenton Saunders ...

Business as usual at Allergan, says chief Takeover reports played down by MD of Allergan Pharmaceuticals Ireland Áine Ryan REPORTS in international and local media about a hostile takeover of global ...